A pharmaceutical firm merges with a German group | Midlands Offers News

A Leicestershire-based pharmaceutical and healthcare services consultancy has merged with a German group in a deal backed by Alantra’s offices in Birmingham and London.

Founded in 2013, NeoHealthHub (NHH) supports its clients by offering market access, data and capacity development services at all phases of the lifecycle of pharmaceutical and healthcare brands.

The company merged with the German company PharmaLex, a specialist service provider for the pharmaceutical, biotechnology and medical industries worldwide.

NHH is headquartered in Lutterworth and employs around 50 people.

Dr. Thomas Dobmeyer, CEO of Pharmalex, said: “The merger with NHH is a welcome step for both of our businesses and we are delighted to welcome the talented and knowledgeable team of market access, data and in capacities.

“By combining our expertise, we are better able to support our customers globally with their market access, data and capacity needs, while building a highly successful local market access business. which now includes the UK.”

The transaction was led by Anthony Harrington, Partner at Alantra, supported by Matt Kumeta, Vice President, and Tom Tett, Partner, all members of the Alantra Healthcare team.

Harrington said: “It was a pleasure advising Simon and his team on the merger of NeoHealthHub with PharmaLex.

“This transaction also demonstrates Alantra’s continued strength in medical communications mergers and acquisitions and in pharmaceutical commercialization more generally – this is our ninth transaction in the past two years alone, with several more in the pipeline.

“We continue to see strong interest from strategic and private investors in this sector.”

Simon Doyle, Managing Director of NeoHealthHub, added: “We have known Anthony for several years and met regularly to discuss strategy, when would be a good time to partner with another company and prepare NHH for a transaction. This guidance and preparation proved invaluable as we began the process with PharmaLex.

“The Alantra team was everything we could ask for in a trusted advisor. They understood our business model and market dynamics, identified key value drivers and provided the strategic advice we needed to ensure a successful achievement.

“We have achieved a great result with a partner who shares similar values ​​and corporate culture and has created an organization that allows us to operate in a truly agile way, maximizing opportunities as they arise.

James R. Rhodes